Skip to main navigation Skip to search Skip to main content

An in silico evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer

  • Richard Junior Zapata Dongo
  • , Julio A. Poterico
  • , Diletta Fontana
  • , Luca Mologni
  • , Carla Alvarez-Chacon
  • , Juan Rojas-Armas
  • , Jaeson Calla

Research output: Contribution to journal › Original Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'An in silico evaluation of lorlatinib as a potential therapy for novel amino acid substitutions in the tyrosine kinase domain of the ALK protein associated with cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology